Computational Modelling in Polycystic Ovary Syndrome: A Comprehensive Review
International Journal of Drug Delivery Technology · 17.06.2026 · 16 (55s)
DOI: 10.25258/ijddt.16.55s.36 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 17.06.2026. Verfasst von Prashant Kumbhar und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Polycystic ovary syndrome (PCOS) is a complex endocrine and metabolic condition that affects up to 15% of reproductive-age women. Traditional diagnostic and treatment frameworks struggle to address the syndrome's heterogeneity. The development of artificial intelligence (AI), in-silico modelling, and virtual patient simulations has created a new paradigm for studying PCOS pathogenesis and optimising individualised care.
Purpose
This review synthesizes current advances in AI-driven virtual patient modelling, machine learning prediction, systems-biology simulations, and computational pharmacology applied to PCOS.
Methods
A Narrative style review was carried out, reviewing peer-reviewed studies on AI, predictive modelling, virtual trials, machine learning, and in-silico pharmacokinetics. 50 to 60 consecutive papers covering the entire computational spectrum in PCOS were thoroughly examined.
Results
Virtual patient frameworks accurately replicated hormonal oscillations, metabolic states, and therapy outcomes. Regression-based models identified significant determinants of symptom severity. In-silico ADMET analysis determined the safety and drug-likeness of ovulation induction treatments. Systems biology models revealed that nutraceutical combinations have synergistic benefits. Machine learning models applied to EHR data demonstrated great diagnosis accuracy (AUCs up to 0.85).
Conclusion
AI-driven computational techniques provide excellent tools for analysing PCOS complexity. Their combination improves early detection, predicts treatment outcomes, and speeds therapeutic development. Such strategies contribute to a future in which PCOS care is guided by precision modelling rather than empirical trial and error.
Zitieren
APA
Kumbhar, P., Jawahire, M. S., Burli, S. C., Dhole, V., & Patil, M. A. (2026). Computational Modelling in Polycystic Ovary Syndrome: A Comprehensive Review. International Journal of Drug Delivery Technology, 16(55s). https://doi.org/10.25258/ijddt.16.55s.36
Vancouver
Kumbhar P, Jawahire MS, Burli SC, Dhole V, Patil MA. Computational Modelling in Polycystic Ovary Syndrome: A Comprehensive Review. International Journal of Drug Delivery Technology. 2026;16(55s). doi:10.25258/ijddt.16.55s.36
BibTeX
@article{Kumbhar2026,
author = {Kumbhar, Prashant and Jawahire, Miss Sayali and Burli, S. C and Dhole, Vikas and Patil, Miss Ankita},
title = {Computational Modelling in Polycystic Ovary Syndrome: A Comprehensive Review},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {55s},
doi = {10.25258/ijddt.16.55s.36}
}
EUVIMED